EUVIMEDEUVIMED entdecken
Validierungsstudie

Integrative Bioinformatics and Experimental Validation Identify LOX as a Glycolysis-Related Biomarker in Myocardial Ischemia–Reperfusion Injury

Liying Wang, Zhian Chen, Tianying Liu, Yan Cui, Rui Zhang, Yong Cui, Zhi Liu

Cardiovascular Toxicology · 2026-07 · 26 (7)

DOI: 10.1007/s12012-026-10145-4 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Cardiovascular Toxicology, online erschienen am 25.06.2026. Verfasst von Liying Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrated Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Glycolysis, Computational Biology, Myocytes, Cardiac. Die Arbeit nennt 46 Literaturangaben. Gefördert von: the Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reprogramming of glycolytic metabolism plays a critical role in the pathogenesis of myocardial ischemia-reperfusion injury (MIRI). Although transient glycolysis activation may alleviate energy deficits, excessive glycolytic flux can worsen myocardial damage. This study aimed to identify specific biomarkers and therapeutic targets by investigating glycolysis-related genes in MIRI. We analyzed differentially expressed genes (DEGs) from GEO datasets GSE61592 and GSE160516 and constructed co-expression modules using weighted gene co-expression network analysis (WGCNA). By intersecting DEGs, WGCNA modules, and glycolysis-related genes, we identified glycolysis-related DEGs (GR-DEGs). Machine learning (support vector machine-recursive feature elimination and Random Forest) was applied to GR-DEGs; LOX emerged as the top intersecting feature (log2FC = 3. 67, adjusted P = 1. 44 × 10⁻⁵, validation set AUC = 0. 97). Diagnostic value was assessed using gene set enrichment analysis (GSEA), decision curve analysis (DCA), and nomogram modeling. Immune infiltration was evaluated using CIBERSORT. Experimental validation was conducted in a rat MIRI model and H9c2 hypoxia-reoxygenation (H/R) cells. GR-DEGs were enriched in pathways including ribose phosphate metabolism, collagen binding, and apoptosis. Machine learning identified LOX as a hub gene, significantly upregulated in both models. Functional analysis suggested LOX expression was significantly associated with extracellular matrix (ECM) receptor interaction pathways, with its upregulation coinciding with myocardial injury progression. LOX expression correlated positively with CD8⁺ T cells and activated memory CD4⁺ T cells, indicating its potential association with metabolic and immune microenvironment remodeling in MIRI. Our findings suggest that LOX may serve as a key candidate gene associated with MIRI pathogenesis in preclinical models, with a potential value for preclinical research exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryGlycolysisComputational BiologyMyocytes, CardiacAnimalsGene Expression ProfilingDisease Models, AnimalCell LineDatabases, GeneticRatsSignal TransductionGene Regulatory NetworksReproducibility of ResultsMaleRats, Sprague-DawleyBiomarkers

Stichwörter der Autor:innen

BiomarkersGlycolysisLOXMachine learningMyocardial ischemia-reperfusion injury

Substanzen

Biomarkers

Autor:innen und Institutionen

  • School of Integrated Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, China.
  • School of Basic Medical Sciences, Changchun University of Chinese Medicine, Changchun, 130117, China.
  • Paediatrics Clinic, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, 130021, China.
  • Jilin Provincial Center for Disease Control and Prevention, Changchun, 130051, China. 8098506@qq.com.
  • School of Clinical Medicine, Changchun University of Chinese Medicine, Changchun, 130117, China. liuzhi01@ccucm.edu.cn.

Förderung

  • the Natural Science Foundation of Jilin Province

Zitieren

APA

Wang, L., Chen, Z., Liu, T., Cui, Y., Zhang, R., Cui, Y., & Liu, Z. (2026). Integrative Bioinformatics and Experimental Validation Identify LOX as a Glycolysis-Related Biomarker in Myocardial Ischemia–Reperfusion Injury. Cardiovascular Toxicology, 26(7). https://doi.org/10.1007/s12012-026-10145-4

Vancouver

Wang L, Chen Z, Liu T, Cui Y, Zhang R, Cui Y, et al. Integrative Bioinformatics and Experimental Validation Identify LOX as a Glycolysis-Related Biomarker in Myocardial Ischemia–Reperfusion Injury. Cardiovascular Toxicology. 2026;26(7). doi:10.1007/s12012-026-10145-4

BibTeX
@article{Wang2026,
  author = {Wang, Liying and Chen, Zhian and Liu, Tianying and Cui, Yan and Zhang, Rui and Cui, Yong and Liu, Zhi},
  title = {Integrative Bioinformatics and Experimental Validation Identify LOX as a Glycolysis-Related Biomarker in Myocardial Ischemia–Reperfusion Injury},
  journal = {Cardiovascular Toxicology},
  year = {2026},
  volume = {26},
  number = {7},
  doi = {10.1007/s12012-026-10145-4}
}
Kostenlos starten →